14 November 2024
How Conferences Strengthen Your Role as a Vitiligo Patient Leader
Attending conferences like the VIPOC (Vitiligo International Patient Organization Committee)…
21 October 2024
Incyte Announces Health Canada Approval of OPZELURA® (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo
News provided by Incyte Biosciences Canada - First and only…
7 October 2024
EADV Amsterdam 25-28 September 2024
During the EADV conference held in Amsterdam from September 25…
4 October 2024
Skin and Digital–The 2024 Narrative
Dominique du Crest, MBEa ducrest@skinaid.eu ∙ Monisha Madhumita, MDb ∙ Wendemagegn Enbiale, MD, MPH, PhDc ∙ Alexander Zink, MD, MPH, PhDd ∙ Art Papier, MDe ∙ Gaone Matewa, BBAf ∙ Harvey Castro, MD, MBAg ∙ Hector Perandones, MDh ∙ Josef De Guzman, OD-OPSi ∙ Misha Rosenbach, MDj ∙ Tu-Anh Duong, MD, PhDk ∙ Yu-Chuan Jack Li, MD,…
5 July 2024
World Vitiligo Day 2024 Highlights
We are thrilled to announce that World Vitiligo Day was…
3 July 2024
Vitiligo recognised as a disease in D.R. Congo
The Provincial Minister of Health of Haut-Katanga (Democratic Republic of…
